Open AccessOptimal Choice of Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer: Clinical Insights
Author(s) -
Mairi W Lucas,
Catherine M. Kelly
Publication year - 2022
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s341466
Subject(s) - taxane , oncology , breast cancer , medicine , neoadjuvant therapy , anthracycline , chemotherapy , trastuzumab , pembrolizumab , docetaxel , cancer , clinical trial , immunotherapy